Replies to post #2159 on Cellectar Biosciences Inc (CLRB)

[dcunited94]

3/29/2011 SHORT INTEREST DAILY UPDATE

Between 3/3/2011 and 3/29/2011 - 44.21% - 6,529,653 shares short / total daily vol. 14,768,626


3/3/2011 - 55.76% - 166,000 shares short / total daily vol. 297,695
3/4/2011 - 26.24% - 29,350 shares short / total daily vol. 111,853
3/7/2011 - 13.84% - 95,750 shares short / total daily vol. 691,650
3/8/2011 - 27.10% - 100,000 shares short / total daily vol. 369,000
3/9/2011 - 42.84% - 147,400 shares short / total daily vol. 344,100
3/10/2011 - 24.46% - 96,300 shares short / total daily vol. 393,740
3/11/2011 - 38.79% - 60,200 shares short / total daily vol. 155,200
3/14/2011 - 33.90% - 50,500 shares short / total daily vol. 148,966
3/15/2011 - 48.32% - 424,397 shares short / total daily vol. 878,394
3/16/2011 - 59.31% - 771,861 shares short / total daily vol. 1,301,361
3/17/2011 - 50.63% - 650,000 shares short / total daily vol. 1,283,778
3/18/2011 - 58.92% - 306,000 shares short / total daily vol. 519,332
3/21/2011 - 57.95% - 75,200 shares short / total daily vol. 129,770
3/22/2011 - 67.53% - 390,000 shares short / total daily vol. 577,500
3/23/2011 - 67.38% - 237,500 shares short / total daily vol. 352,500
3/24/2011 - 17.23% - 124,780 shares short / total daily vol. 723,996
3/25/2011 - 89.35% - 1,443,615 shares short / total daily vol. 1,615,741
3/28/2011 - 23.07% - 957,800 shares short / total daily vol. 4,152,600
3/29/2011 - 55.86% - 403,000 shares short / total daily vol. 721,450

ORF Section 
regsho.finra.org/regsho-Index.html

Disclaimer
*Exclusive of Form-T trades. Using data reported to the regulator, FINRA, over brokerage platforms (i.e. E*Trade)

[dcunited94]

I was at the doctors and shopping to get a clean bill of health and improve my wardrobe to coincide with the glitz and glam of Dubai before I move their in 2.5 weeks.

Anyways.... I usually would not post this... but whatever...
I figure it's worth peoples read...

From: Harry Palmin [mailto:[e-mail]]
Sent: Monday, March 28, 2011 2:01 PM
To: XXXXX, XXXXX
Cc: [e-mail]
Subject: RE: NVLT Update 3.1.2011

Hello XXXXX,

I cannot comment beyond publicly available information. We continue to work diligently on implementing the third step of the rebuilding process.

Best,

Harry

________________________________________
From: XXXXX, XXXXX [mailto:[e-mail]]
Sent: Monday, March 28, 2011 1:33 PM
To: Harry Palmin
Cc: [e-mail]; Steve Lichaw/Cayuga Advisors
Subject: RE: NVLT Update 3.1.2011
Harry,

Thanks. Always good to reaffirm your position.

I’m trying my best to stave away from the daily movements regarding the share price. I believe it is currently indicative of technical trading/market manipulation – the short interest is very high (reaching 89% on last Friday’s trading session); therefore, do not believe it accurately depict future advances/information.

Do you anticipate any press releases prior to 3/31/11 – the due date for the 10-K and additionally, do you expect an extension to be filed based on the current situation at Novelos (i.e. potential negotiations for new funding/acquisition or merger etc…). Per previous e-mails, your team has been able to accomplish the first 2 of the 3 steps within the rebuilding process. Third step being the most difficult (capital raises/product acquisition), but given your Wall Street roots and Stephen Lichaws restructuring, turnaround, M&A and capital raises background – I figure it’s only a matter of time, not if but when.

XXXXX XXXXX
XXXX


From: Harry Palmin [mailto:[e-mail]]
Sent: Thursday, March 24, 2011 7:25 PM
To: XXXXX, XXXXX
Cc: [e-mail]; 'Steve Lichaw/Cayuga Advisors'
Subject: RE: NVLT Update 3.1.2011

Hi XXXXX,

I have not sold any equity shares of Novelos, before or since NOV-002 failed Ph3 in NSCLC.

Best,

Harry
________________________________________
From: XXXXX, XXXXX [mailto:[e-mail]]
Sent: Thursday, March 24, 2011 10:28 AM
To: Harry Palmin
Cc: [e-mail]; Steve Lichaw/Cayuga Advisors
Subject: RE: NVLT Update 3.1.2011
Harry,

Just want to reconfirm whether you have sold any equity shares since the Phase III failure. Price movement – specifically currently (33.33% drop from yesterdays close) currently at .012 with 512K in volume has me irked.

Any guidance – even the slightest bit here?

XXXXX XXXXX
XXXX


From: Steve Lichaw/Cayuga Advisors [mailto:[e-mail]]
Sent: Wednesday, March 23, 2011 12:27 PM
To: XXXXX, XXXXX; Harry Palmin
Cc: [e-mail]
Subject: Re: NVLT Update 3.1.2011

Nice write up, thanks

Steve Lichaw
201-240-3200


________________________________________
From: "XXXXX, XXXXX" <[e-mail]>
To: Harry Palmin <[e-mail]>
Cc: [e-mail]
Sent: Wed, March 23, 2011 12:23:38 PM
Subject: RE: NVLT Update 3.1.2011
Ok thanks.

Not sure if you’re aware but NOV-002 was mentioned in the following article relating to breast cancer today (3/23/11).

Latest regarding the Women’s Health

XXXXX XXXXX
XXXX


From: Harry Palmin [mailto:[e-mail]]
Sent: Monday, March 21, 2011 11:18 AM
To: XXXXX, XXXXX
Cc: [e-mail]
Subject: RE: NVLT Update 3.1.2011

The filing requirement for 10K is by March 31.

________________________________________
From: XXXXX, XXXXX [mailto:[e-mail]]
Sent: Monday, March 21, 2011 11:14 AM
To: Harry Palmin
Cc: [e-mail]
Subject: RE: NVLT Update 3.1.2011
Thanks Harry.

Just wanted to know when the 10K is slated to be released.

Thanks.

XXXXX XXXXX